NCT00348101View on ClinicalTrials.gov

Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

May 31, 2007

Conditions
Coronary Artery Disease
Interventions
DRUG

Combined therapy with enoximone and esmolol

Trial Locations (1)

67063

Department of Anesthesiology and Intensive Care Medicine Klinikum Ludwigshafen, Ludwigshafen

All Listed Sponsors
lead

Klinikum Ludwigshafen

OTHER

NCT00348101 - Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation | Biotech Hunter | Biotech Hunter